|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:SH3PXD2A-HTRA1 (FusionGDB2 ID:80933) |
Fusion Gene Summary for SH3PXD2A-HTRA1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SH3PXD2A-HTRA1 | Fusion gene ID: 80933 | Hgene | Tgene | Gene symbol | SH3PXD2A | HTRA1 | Gene ID | 9644 | 5654 |
| Gene name | SH3 and PX domains 2A | HtrA serine peptidase 1 | |
| Synonyms | FISH|SH3MD1|TKS5 | ARMD7|CADASIL2|CARASIL|HtrA|L56|ORF480|PRSS11 | |
| Cytomap | 10q24.33 | 10q26.13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | SH3 and PX domain-containing protein 2ASH3 multiple domains 1adapter protein TKS5adaptor protein TKS5five SH3 domain-containing proteintyrosine kinase substrate with five SH3 domains | serine protease HTRA1IGFBP5-proteasehigh-temperature requirement A serine peptidase 1protease, serine, 11 (IGF binding) | |
| Modification date | 20200313 | 20200322 | |
| UniProtAcc | . | Q92743 | |
| Ensembl transtripts involved in fusion gene | ENST00000427662, ENST00000369774, ENST00000355946, ENST00000315994, ENST00000540321, ENST00000538130, | ENST00000368984, | |
| Fusion gene scores | * DoF score | 12 X 20 X 12=2880 | 4 X 5 X 4=80 |
| # samples | 29 | 5 | |
| ** MAII score | log2(29/2880*10)=-3.31194400631474 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: SH3PXD2A [Title/Abstract] AND HTRA1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | SH3PXD2A(105452785)-HTRA1(124248414), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | SH3PXD2A-HTRA1 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | SH3PXD2A | GO:0006801 | superoxide metabolic process | 19755710 |
| Fusion gene breakpoints across SH3PXD2A (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across HTRA1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS5.0 | N/A | AV734257 | SH3PXD2A | chr10 | 105452785 | - | HTRA1 | chr10 | 124248414 | + |
Top |
Fusion Gene ORF analysis for SH3PXD2A-HTRA1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000427662 | ENST00000368984 | SH3PXD2A | chr10 | 105452785 | - | HTRA1 | chr10 | 124248414 | + |
| In-frame | ENST00000369774 | ENST00000368984 | SH3PXD2A | chr10 | 105452785 | - | HTRA1 | chr10 | 124248414 | + |
| In-frame | ENST00000355946 | ENST00000368984 | SH3PXD2A | chr10 | 105452785 | - | HTRA1 | chr10 | 124248414 | + |
| 5UTR-3CDS | ENST00000315994 | ENST00000368984 | SH3PXD2A | chr10 | 105452785 | - | HTRA1 | chr10 | 124248414 | + |
| intron-3CDS | ENST00000540321 | ENST00000368984 | SH3PXD2A | chr10 | 105452785 | - | HTRA1 | chr10 | 124248414 | + |
| intron-3CDS | ENST00000538130 | ENST00000368984 | SH3PXD2A | chr10 | 105452785 | - | HTRA1 | chr10 | 124248414 | + |
| intron-intron | ENST00000315994 | ENST00000368984 | SH3PXD2A | chr10 | 105452814 | - | HTRA1 | chr10 | 105452814 | + |
| intron-intron | ENST00000355946 | ENST00000368984 | SH3PXD2A | chr10 | 105452814 | - | HTRA1 | chr10 | 105452814 | + |
| intron-intron | ENST00000369774 | ENST00000368984 | SH3PXD2A | chr10 | 105452814 | - | HTRA1 | chr10 | 105452814 | + |
| intron-intron | ENST00000427662 | ENST00000368984 | SH3PXD2A | chr10 | 105452814 | - | HTRA1 | chr10 | 105452814 | + |
| intron-intron | ENST00000538130 | ENST00000368984 | SH3PXD2A | chr10 | 105452814 | - | HTRA1 | chr10 | 105452814 | + |
| intron-intron | ENST00000540321 | ENST00000368984 | SH3PXD2A | chr10 | 105452814 | - | HTRA1 | chr10 | 105452814 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000369774 | SH3PXD2A | chr10 | 105452785 | - | ENST00000368984 | HTRA1 | chr10 | 124248414 | + | 2224 | 704 | 202 | 1674 | 490 |
| ENST00000355946 | SH3PXD2A | chr10 | 105452785 | - | ENST00000368984 | HTRA1 | chr10 | 124248414 | + | 2087 | 567 | 65 | 1537 | 490 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000369774 | ENST00000368984 | SH3PXD2A | chr10 | 105452785 | - | HTRA1 | chr10 | 124248414 | + | 0.001724619 | 0.9982754 |
| ENST00000355946 | ENST00000368984 | SH3PXD2A | chr10 | 105452785 | - | HTRA1 | chr10 | 124248414 | + | 0.001396724 | 0.9986033 |
Top |
Fusion Genomic Features for SH3PXD2A-HTRA1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| SH3PXD2A | chr10 | 105452785 | - | HTRA1 | chr10 | 124248417 | + | 0.000195068 | 0.9998049 |
| SH3PXD2A | chr10 | 105452785 | - | HTRA1 | chr10 | 124248417 | + | 0.000195068 | 0.9998049 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for SH3PXD2A-HTRA1 |
| Go to FGviewer for the breakpoints of chr10:105452785-chr10:124248414 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | HTRA1 |
| FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Serine protease with a variety of targets, including extracellular matrix proteins such as fibronectin. HTRA1-generated fibronectin fragments further induce synovial cells to up-regulate MMP1 and MMP3 production. May also degrade proteoglycans, such as aggrecan, decorin and fibromodulin. Through cleavage of proteoglycans, may release soluble FGF-glycosaminoglycan complexes that promote the range and intensity of FGF signals in the extracellular space. Regulates the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. Inhibits signaling mediated by TGF-beta family members. This activity requires the integrity of the catalytic site, although it is unclear whether TGF-beta proteins are themselves degraded. By acting on TGF-beta signaling, may regulate many physiological processes, including retinal angiogenesis and neuronal survival and maturation during development. Intracellularly, degrades TSC2, leading to the activation of TSC2 downstream targets. {ECO:0000269|PubMed:16377621, ECO:0000269|PubMed:20671064, ECO:0000269|PubMed:9852107}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000355946 | - | 6 | 14 | 4_128 | 142.33333333333334 | 1106.0 | Domain | PX |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000369774 | - | 6 | 15 | 4_128 | 142.33333333333334 | 1134.0 | Domain | PX |
| Tgene | HTRA1 | chr10:105452785 | chr10:124248414 | ENST00000368984 | 0 | 9 | 365_467 | 157.33333333333334 | 481.0 | Domain | PDZ | |
| Tgene | HTRA1 | chr10:105452785 | chr10:124248414 | ENST00000368984 | 0 | 9 | 204_364 | 157.33333333333334 | 481.0 | Region | Note=Serine protease |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000355946 | - | 6 | 14 | 917_946 | 142.33333333333334 | 1106.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000369774 | - | 6 | 15 | 917_946 | 142.33333333333334 | 1134.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000355946 | - | 6 | 14 | 634_724 | 142.33333333333334 | 1106.0 | Compositional bias | Note=Ser-rich |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000369774 | - | 6 | 15 | 634_724 | 142.33333333333334 | 1134.0 | Compositional bias | Note=Ser-rich |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000355946 | - | 6 | 14 | 1072_1133 | 142.33333333333334 | 1106.0 | Domain | SH3 5 |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000355946 | - | 6 | 14 | 166_225 | 142.33333333333334 | 1106.0 | Domain | SH3 1 |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000355946 | - | 6 | 14 | 266_325 | 142.33333333333334 | 1106.0 | Domain | SH3 2 |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000355946 | - | 6 | 14 | 448_507 | 142.33333333333334 | 1106.0 | Domain | SH3 3 |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000355946 | - | 6 | 14 | 840_899 | 142.33333333333334 | 1106.0 | Domain | SH3 4 |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000369774 | - | 6 | 15 | 1072_1133 | 142.33333333333334 | 1134.0 | Domain | SH3 5 |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000369774 | - | 6 | 15 | 166_225 | 142.33333333333334 | 1134.0 | Domain | SH3 1 |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000369774 | - | 6 | 15 | 266_325 | 142.33333333333334 | 1134.0 | Domain | SH3 2 |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000369774 | - | 6 | 15 | 448_507 | 142.33333333333334 | 1134.0 | Domain | SH3 3 |
| Hgene | SH3PXD2A | chr10:105452785 | chr10:124248414 | ENST00000369774 | - | 6 | 15 | 840_899 | 142.33333333333334 | 1134.0 | Domain | SH3 4 |
| Tgene | HTRA1 | chr10:105452785 | chr10:124248414 | ENST00000368984 | 0 | 9 | 33_100 | 157.33333333333334 | 481.0 | Domain | IGFBP N-terminal | |
| Tgene | HTRA1 | chr10:105452785 | chr10:124248414 | ENST00000368984 | 0 | 9 | 98_157 | 157.33333333333334 | 481.0 | Domain | Kazal-like |
Top |
Fusion Gene Sequence for SH3PXD2A-HTRA1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >In-frame_ENST00000369774_ENST00000368984_AV734257_SH3PXD2A_chr10_105452785_-_HTRA1_chr10_124248414_length(transcript)=2224nt_BP=704nt GCGAGCGGGCGAGCGCAGCGCGGCGGCCGCGCGGGAGTGAAGGGGCGCGCGGCAGGCCGGCGGGGAGTCCCCCGGGGCGCACGGAGCCCG CGCGCCCTCCGGGACCCTCCCCCGTCCCTGGGCCGGACCTGTGGGCGCCGGGAGTCCGGGCAGCGTTCGGCGCGCCGGGCCGGGGTGGCG GGCGGCCCCGGGACCCCGGCAGCTGGAGAAGGAGCCGGAGCCCGGCCGGGATGAGAAGGTGACGCCGCCGGGGGCGCCACTCGCTTTGTG GGGGAAGATGCTCGCCTACTGCGTGCAGGATGCCACCGTGGTGGACGTGGAGAAGCGGAGGAACCCCTCCAAGCACTACGTATACATAAT CAATGTGACCTGGTCTGACTCCACCTCCCAGACTATCTACCGGAGGTACAGCAAGTTCTTTGACCTGCAGATGCAGCTTTTGGATAAGTT TCCCATTGAAGGTGGCCAGAAGGACCCCAAGCAAAGGATCATCCCCTTCCTCCCAGGCAAGATCCTCTTCCGCAGAAGCCACATCCGGGA CGTAGCTGTGAAGAGACTGAAGCCCATCGATGAATACTGCCGGGCACTTGTCCGGCTGCCCCCCCACATCTCACAGTGTGACGAAGTCTT CCGGTTCTTCGAGGCTCGACCCGAGGATGTCAACCCTCCAAAAGAGGACTATGGCAGTTCCAAGAGGAAATCAGGGCAGGAAGATCCCAA CAGTTTGCGCCATAAATATAACTTTATCGCGGACGTGGTGGAGAAGATCGCCCCTGCCGTGGTTCATATCGAATTGTTTCGCAAGCTTCC GTTTTCTAAACGAGAGGTGCCGGTGGCTAGTGGGTCTGGGTTTATTGTGTCGGAAGATGGACTGATCGTGACAAATGCCCACGTGGTGAC CAACAAGCACCGGGTCAAAGTTGAGCTGAAGAACGGTGCCACTTACGAAGCCAAAATCAAGGATGTGGATGAGAAAGCAGACATCGCACT CATCAAAATTGACCACCAGGGCAAGCTGCCTGTCCTGCTGCTTGGCCGCTCCTCAGAGCTGCGGCCGGGAGAGTTCGTGGTCGCCATCGG AAGCCCGTTTTCCCTTCAAAACACAGTCACCACCGGGATCGTGAGCACCACCCAGCGAGGCGGCAAAGAGCTGGGGCTCCGCAACTCAGA CATGGACTACATCCAGACCGACGCCATCATCAACTATGGAAACTCGGGAGGCCCGTTAGTAAACCTGGACGGTGAAGTGATTGGAATTAA CACTTTGAAAGTGACAGCTGGAATCTCCTTTGCAATCCCATCTGATAAGATTAAAAAGTTCCTCACGGAGTCCCATGACCGACAGGCCAA AGGAAAAGCCATCACCAAGAAGAAGTATATTGGTATCCGAATGATGTCACTCACGTCCAGCAAAGCCAAAGAGCTGAAGGACCGGCACCG GGACTTCCCAGACGTGATCTCAGGAGCGTATATAATTGAAGTAATTCCTGATACCCCAGCAGAAGCTGGTGGTCTCAAGGAAAACGACGT CATAATCAGCATCAATGGACAGTCCGTGGTCTCCGCCAATGATGTCAGCGACGTCATTAAAAGGGAAAGCACCCTGAACATGGTGGTCCG CAGGGGTAATGAAGATATCATGATCACAGTGATTCCCGAAGAAATTGACCCATAGGCAGAGGCATGAGCTGGACTTCATGTTTCCCTCAA AGACTCTCCCGTGGATGACGGATGAGGACTCTGGGCTGCTGGAATAGGACACTCAAGACTTTTGACTGCCATTTTGTTTGTTCAGTGGAG ACTCCCTGGCCAACAGAATCCTTCTTGATAGTTTGCAGGCAAAACAAATGTAATGTTGCAGATCCGCAGGCAGAAGCTCTGCCCTTCTGT ATCCTATGTATGCAGTGTGCTTTTTCTTGCCAGCTTGGGCCATTCTTGCTTAGACAGTCAGCATTTGTCTCCTCCTTTAACTGAGTCATC ATCTTAGTCCAACTAATGCAGTCGATACAATGCGTAGATAGAAGAAGCCCCACGGGAGCCAGGATGGGACTGGTCGTGTTTGTGCTTTTC TCCAAGTCAGCACCCAAAGGTCAATGCACAGAGACCCCGGGTGGGTGAGCGCTGGCTTCTCAAACGGCCGAAGTTGCCTCTTTTAGGAAT >In-frame_ENST00000369774_ENST00000368984_AV734257_SH3PXD2A_chr10_105452785_-_HTRA1_chr10_124248414_length(amino acids)=490AA_start in transcript=202_stop in transcript=1674 MEKEPEPGRDEKVTPPGAPLALWGKMLAYCVQDATVVDVEKRRNPSKHYVYIINVTWSDSTSQTIYRRYSKFFDLQMQLLDKFPIEGGQK DPKQRIIPFLPGKILFRRSHIRDVAVKRLKPIDEYCRALVRLPPHISQCDEVFRFFEARPEDVNPPKEDYGSSKRKSGQEDPNSLRHKYN FIADVVEKIAPAVVHIELFRKLPFSKREVPVASGSGFIVSEDGLIVTNAHVVTNKHRVKVELKNGATYEAKIKDVDEKADIALIKIDHQG KLPVLLLGRSSELRPGEFVVAIGSPFSLQNTVTTGIVSTTQRGGKELGLRNSDMDYIQTDAIINYGNSGGPLVNLDGEVIGINTLKVTAG ISFAIPSDKIKKFLTESHDRQAKGKAITKKKYIGIRMMSLTSSKAKELKDRHRDFPDVISGAYIIEVIPDTPAEAGGLKENDVIISINGQ -------------------------------------------------------------- >In-frame_ENST00000355946_ENST00000368984_AV734257_SH3PXD2A_chr10_105452785_-_HTRA1_chr10_124248414_length(transcript)=2087nt_BP=567nt CCGGGAGTCCGGGCAGCGTTCGGCGCGCCGGGCCGGGGTGGCGGGCGGCCCCGGGACCCCGGCAGCTGGAGAAGGAGCCGGAGCCCGGCC GGGATGAGAAGGTGACGCCGCCGGGGGCGCCACTCGCTTTGTGGGGGAAGATGCTCGCCTACTGCGTGCAGGATGCCACCGTGGTGGACG TGGAGAAGCGGAGGAACCCCTCCAAGCACTACGTATACATAATCAATGTGACCTGGTCTGACTCCACCTCCCAGACTATCTACCGGAGGT ACAGCAAGTTCTTTGACCTGCAGATGCAGCTTTTGGATAAGTTTCCCATTGAAGGTGGCCAGAAGGACCCCAAGCAAAGGATCATCCCCT TCCTCCCAGGCAAGATCCTCTTCCGCAGAAGCCACATCCGGGACGTAGCTGTGAAGAGACTGAAGCCCATCGATGAATACTGCCGGGCAC TTGTCCGGCTGCCCCCCCACATCTCACAGTGTGACGAAGTCTTCCGGTTCTTCGAGGCTCGACCCGAGGATGTCAACCCTCCAAAAGAGG ACTATGGCAGTTCCAAGAGGAAATCAGGGCAGGAAGATCCCAACAGTTTGCGCCATAAATATAACTTTATCGCGGACGTGGTGGAGAAGA TCGCCCCTGCCGTGGTTCATATCGAATTGTTTCGCAAGCTTCCGTTTTCTAAACGAGAGGTGCCGGTGGCTAGTGGGTCTGGGTTTATTG TGTCGGAAGATGGACTGATCGTGACAAATGCCCACGTGGTGACCAACAAGCACCGGGTCAAAGTTGAGCTGAAGAACGGTGCCACTTACG AAGCCAAAATCAAGGATGTGGATGAGAAAGCAGACATCGCACTCATCAAAATTGACCACCAGGGCAAGCTGCCTGTCCTGCTGCTTGGCC GCTCCTCAGAGCTGCGGCCGGGAGAGTTCGTGGTCGCCATCGGAAGCCCGTTTTCCCTTCAAAACACAGTCACCACCGGGATCGTGAGCA CCACCCAGCGAGGCGGCAAAGAGCTGGGGCTCCGCAACTCAGACATGGACTACATCCAGACCGACGCCATCATCAACTATGGAAACTCGG GAGGCCCGTTAGTAAACCTGGACGGTGAAGTGATTGGAATTAACACTTTGAAAGTGACAGCTGGAATCTCCTTTGCAATCCCATCTGATA AGATTAAAAAGTTCCTCACGGAGTCCCATGACCGACAGGCCAAAGGAAAAGCCATCACCAAGAAGAAGTATATTGGTATCCGAATGATGT CACTCACGTCCAGCAAAGCCAAAGAGCTGAAGGACCGGCACCGGGACTTCCCAGACGTGATCTCAGGAGCGTATATAATTGAAGTAATTC CTGATACCCCAGCAGAAGCTGGTGGTCTCAAGGAAAACGACGTCATAATCAGCATCAATGGACAGTCCGTGGTCTCCGCCAATGATGTCA GCGACGTCATTAAAAGGGAAAGCACCCTGAACATGGTGGTCCGCAGGGGTAATGAAGATATCATGATCACAGTGATTCCCGAAGAAATTG ACCCATAGGCAGAGGCATGAGCTGGACTTCATGTTTCCCTCAAAGACTCTCCCGTGGATGACGGATGAGGACTCTGGGCTGCTGGAATAG GACACTCAAGACTTTTGACTGCCATTTTGTTTGTTCAGTGGAGACTCCCTGGCCAACAGAATCCTTCTTGATAGTTTGCAGGCAAAACAA ATGTAATGTTGCAGATCCGCAGGCAGAAGCTCTGCCCTTCTGTATCCTATGTATGCAGTGTGCTTTTTCTTGCCAGCTTGGGCCATTCTT GCTTAGACAGTCAGCATTTGTCTCCTCCTTTAACTGAGTCATCATCTTAGTCCAACTAATGCAGTCGATACAATGCGTAGATAGAAGAAG CCCCACGGGAGCCAGGATGGGACTGGTCGTGTTTGTGCTTTTCTCCAAGTCAGCACCCAAAGGTCAATGCACAGAGACCCCGGGTGGGTG AGCGCTGGCTTCTCAAACGGCCGAAGTTGCCTCTTTTAGGAATCTCTTTGGAATTGGGAGCACGATGACTCTGAGTTTGAGCTATTAAAG >In-frame_ENST00000355946_ENST00000368984_AV734257_SH3PXD2A_chr10_105452785_-_HTRA1_chr10_124248414_length(amino acids)=490AA_start in transcript=65_stop in transcript=1537 MEKEPEPGRDEKVTPPGAPLALWGKMLAYCVQDATVVDVEKRRNPSKHYVYIINVTWSDSTSQTIYRRYSKFFDLQMQLLDKFPIEGGQK DPKQRIIPFLPGKILFRRSHIRDVAVKRLKPIDEYCRALVRLPPHISQCDEVFRFFEARPEDVNPPKEDYGSSKRKSGQEDPNSLRHKYN FIADVVEKIAPAVVHIELFRKLPFSKREVPVASGSGFIVSEDGLIVTNAHVVTNKHRVKVELKNGATYEAKIKDVDEKADIALIKIDHQG KLPVLLLGRSSELRPGEFVVAIGSPFSLQNTVTTGIVSTTQRGGKELGLRNSDMDYIQTDAIINYGNSGGPLVNLDGEVIGINTLKVTAG ISFAIPSDKIKKFLTESHDRQAKGKAITKKKYIGIRMMSLTSSKAKELKDRHRDFPDVISGAYIIEVIPDTPAEAGGLKENDVIISINGQ -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for SH3PXD2A-HTRA1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SH3PXD2A-HTRA1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SH3PXD2A-HTRA1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | SH3PXD2A | C0004238 | Atrial Fibrillation | 1 | CTD_human |
| Hgene | SH3PXD2A | C0036341 | Schizophrenia | 1 | PSYGENET |
| Hgene | SH3PXD2A | C0038454 | Cerebrovascular accident | 1 | CTD_human |
| Hgene | SH3PXD2A | C0206729 | Neurofibrosarcoma | 1 | ORPHANET |
| Hgene | SH3PXD2A | C0235480 | Paroxysmal atrial fibrillation | 1 | CTD_human |
| Hgene | SH3PXD2A | C0751690 | Malignant Peripheral Nerve Sheath Tumor | 1 | ORPHANET |
| Hgene | SH3PXD2A | C0751956 | Acute Cerebrovascular Accidents | 1 | CTD_human |
| Hgene | SH3PXD2A | C2585653 | Persistent atrial fibrillation | 1 | CTD_human |
| Hgene | SH3PXD2A | C3468561 | familial atrial fibrillation | 1 | CTD_human |
| Tgene | HTRA1 | C1838577 | Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy | 7 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Tgene | HTRA1 | C4225211 | CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2 | 3 | GENOMICS_ENGLAND;UNIPROT |
| Tgene | HTRA1 | C0002170 | Alopecia | 1 | GENOMICS_ENGLAND |
| Tgene | HTRA1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
| Tgene | HTRA1 | C0158266 | Intervertebral Disc Degeneration | 1 | GENOMICS_ENGLAND |
| Tgene | HTRA1 | C0206729 | Neurofibrosarcoma | 1 | ORPHANET |
| Tgene | HTRA1 | C0242379 | Malignant neoplasm of lung | 1 | CTD_human |
| Tgene | HTRA1 | C0338656 | Impaired cognition | 1 | GENOMICS_ENGLAND |
| Tgene | HTRA1 | C0497327 | Dementia | 1 | GENOMICS_ENGLAND |
| Tgene | HTRA1 | C0751690 | Malignant Peripheral Nerve Sheath Tumor | 1 | ORPHANET |
| Tgene | HTRA1 | C2733158 | Cerebral Small Vessel Diseases | 1 | GENOMICS_ENGLAND |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies